Navamedic ASA: Expands Imdur® distribution to Greece
Oslo, 9 May 2019 – Navamedic ASA (OSE: NAVA) today announced it is expanding distribution of the angina prevention medicine, Imdur®, to Greece, bringing the distribution to a total of 14 markets across Europe. “It is a pleasure to announce that Navamedic is expanding its distribution of Imdur to Greece from the end of April. Imdur is part of a strategic partnership with TopRidge Pharma Limited, under which the product has become Navamedic’s largest single brand. Although the generic competition has increased over the last years, the product is highly important for our customers and for